Evidence map›Paper›PMID 29642438›Full record

ArticleInternational journal of molecular sciences2018

Sesamol Inhibited Melanogenesis by Regulating Melanin-Related Signal Transduction in B16F10 Cells.

Po-Yuan Wu, Ya-Jhen You, Yi-Jung Liu, Chien-Wei Hou, Chin-Sheng Wu, Kuo-Ching Wen, Chien-Yih Lin, Hsiu-Mei Chiang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. FeNanomaterials (Basel, Switzerland) · 2025
    Article
  4. Article
  5. GiantInternational journal of molecular medicine · 2025
    Article
  6. Article
  7. Anti-Melanogenic Activities ofFoods (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Heliyon · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Role of Phytochemicals in Skin PhotoprotectionFrontiers in pharmacology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Antimelanogenesis Effects of Theasinensin A.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Po-Yuan WuDepartment of Dermatology, China Medical University Hospital, Taichung 40402, Taiwan. wu.poyuan@gmail.com.
Ya-Jhen YouDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan. jenn123gay@yahoo.com.tw.
Yi-Jung LiuDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan. ella8175@hotmail.com.
Chien-Wei HouDepartment of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, Hsinchu 30015, Taiwan. rolis.hou@mail.ypu.edu.tw.
Chin-Sheng WuDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan. cswu@mail.cmu.edu.tw.
Kuo-Ching WenDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan. kcwen0520@mail.cmu.edu.tw.
Chien-Yih LinDepartment of Biotechnology, Asia University, Taichung 41354, Taiwan. yihlin@asia.edu.tw.
Hsiu-Mei ChiangDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan. hmchiang@mail.cmu.edu.tw.ORCID 0000-0002-1586-910X
China Medical University · TWAsia University · TWYuanpei University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanin is synthesized through a series of interactions catalyzed by melanogenic enzymes such as tyrosinase, dopachrome tautomerase (tyrosinase-related protein-2; TRP-2), and tyrosinase-related protein-1 (TRP-1). Tyrosinase plays a key role in catalysing the initial and limiting steps of melanogenesis. The melanin that results from melanogenesis has the protective effect of absorbing ultraviolet radiation. However, overproduction of melanin, in addition to altering the appearance of skin, may lead to skin disorders such as melasma, solar lentigo, and postinflammatory hyperpigmentation. Previous studies have revealed that sesamol is a strong antioxidant and a free radical scavenger. In this study, we investigated the effects of sesamol on the regulation of melanogenesis and related mechanisms in B16F10 cells. The results indicated that sesamol inhibited tyrosinase activity and melanogenesis induced by α-melanocyte-stimulating hormone (α-MSH) in B16F10 melanoma cells. Sesamol decreased the protein level of melanocortin 1 receptor (MC1R), microphthalmia-associated transcription factor (MITF), tyrosinase, and TRP-1 by downregulating cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathways that had been activated by α-MSH. Sesamol increased glycogen synthase kinase 3 beta (GSK3β), protein kinase B (AKT), and extracellular signal-related kinase (ERK) phosphorylation, thus inhibiting the transcription of MITF. Sesamol also inhibited melanin synthesis and tyrosinase expression by modulating ERK, phosphoinositide 3-kinase (PI3K)/AKT, p38, and c-Jun amino-terminal kinase (JNK) signalling pathways. These results indicate that sesamol acted as a potent depigmenting agent.

Indexed as

AnimalsAntioxidantsBenzodioxolesCell Line, TumorDown-RegulationGene Expression RegulationMelaninsMiceMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenaseOxidoreductasesPhenolsReceptor, Melanocortin, Type 1Signal TransductionAntioxidantsBenzodioxolesMelaninsMicrophthalmia-Associated Transcription FactorMitf protein, mouseMonophenol MonooxygenaseOxidoreductasesPhenolsReceptor, Melanocortin, Type 1sesamoltyrosinase-related protein-1glycogen synthase kinase 3 beta (GSK3β)melanocortin 1 receptor (MC1R)melanogenesismicrophthalmia-associated transcription factor (MITF)sesamoltyrosinase

Identifiers

PMID29642438
PMCPMC5979541
OpenAlexW2795500143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.